MAIA Biotechnology, Inc. (MAIA) Return on equity 2022–2024
MAIA Biotechnology, Inc. (MAIA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-639.8%FY2024 · since FY2022: -185.4% → -639.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -639.8% | +3501.0 pp |
| FY2023 | -4140.8% | -3955.5 pp |
| FY2022 | -185.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More MAIA financial trends
MAIA RevenueMAIA Net incomeMAIA Net marginMAIA Gross profitMAIA Gross marginMAIA Operating incomeMAIA Operating marginMAIA Operating cash flowMAIA Free cash flowMAIA Capital expendituresMAIA Stock buybacksMAIA Dividends paidMAIA Total assetsMAIA Total liabilitiesMAIA Shareholders’ equityMAIA overview →